Jubilant Pharmova Ltd.

BSE: 530019 | NSE: JUBLPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE700A01033 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Jubilant Pharm Jubilant Pharmova Ltd. | BSE 1096.00 -23.60 (-2.11%) | NSE 1101.00 -17.40 (-1.56%) | Trade | Add

BSE Live

Oct 31, 16:01

1096.00 -23.60 (-2.11%)

Volume

AVERAGE VOLUME

5-Day

4,956

10-Day

7,887

30-Day

7,496

26,928

Prev. Close

1119.60
Open Price

1117.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Oct 31, 15:56

1101.00 -17.40 (-1.56%)

Volume

AVERAGE VOLUME

5-Day

247,205

10-Day

201,944

30-Day

163,960

543,963

Prev. Close

1118.40
Open Price

1115.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1101.00 (2053)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Jubilant Pharmova (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	7,192.10	6,644.80	6,219.30	6,059.17	5,963.88
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	7,192.10	6,644.80	6,219.30	6,059.17	5,963.88
Total Operating Revenues	7,234.50	6,702.90	6,281.73	6,130.16	6,098.54
Other Income	56.80	68.70	38.33	11.29	17.64
Total Revenue	7,291.30	6,771.60	6,320.06	6,141.45	6,116.17
EXPENSES
Cost Of Materials Consumed	1,985.30	1,821.30	1,666.41	1,348.70	1,348.75
Purchase Of Stock-In Trade	297.10	241.20	252.22	201.62	167.63
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FGWIP And Stock In Trade	34.60	78.20	-40.70	-62.32	19.63
Employee Benefit Expenses	2,267.90	2,216.00	2,166.02	2,043.39	1,922.88
Finance Costs	240.30	272.30	188.20	145.49	184.10
Depreciation And Amortisation Expenses	368.60	381.90	554.03	381.70	348.95
Other Expenses	1,475.90	1,445.40	1,461.53	1,442.44	1,243.18
Total Expenses	6,669.70	6,456.30	6,247.71	5,501.02	5,235.12
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	621.60	315.30	72.35	640.43	881.06
Exceptional Items	359.50	-168.90	-56.82	0.00	-21.23
Profit/Loss Before Tax	981.10	146.40	15.53	640.43	859.82
Tax Expenses-Continued Operations
Current Tax	213.20	202.60	181.09	172.55	269.91
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-68.90	-104.80	-88.42	44.88	27.31
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	144.30	97.80	92.66	217.43	297.22
Profit/Loss After Tax And Before ExtraOrdinary Items	836.80	48.60	-77.13	423.00	562.61
Profit/Loss From Continuing Operations	836.80	48.60	-77.13	423.00	562.61
Profit/Loss For The Period	836.80	48.60	-77.13	423.00	824.36
Minority Interest	3.10	4.40	3.90	0.92	0.26
Consolidated Profit/Loss After MI And Associates	839.40	77.10	-60.98	413.94	835.87
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	53.00	5.00	-4.00	26.00	52.00
Diluted EPS (Rs.)	53.00	5.00	-4.00	26.00	52.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	79.60	79.60	79.64	79.64	0.00
Tax On Dividend	0.00	0.00	0.00	0.00	0.00